Category: ‘Clinical Trials and Studies’


Orthocell Delivers Outstanding Results in Remplir™ Nerve Regeneration Trial

Posted on June 7th, 2022

Read more of Orthocell Delivers Outstanding Results in Remplir™ Nerve Regeneration Trial »


Keio University Uses iPS Cells in First Treatment of Spinal Cord Injury

Posted on January 15th, 2022

Keio University in Tokyo said Friday it has started the world’s first clinical test using induced pluripotent stem cells, or iPS cells, to treat patients with spinal cord injuries.

iPS Cells
Cells derived from iPS cells and which will grow into nerve cells | KEIO UNIVERSITY / VIA KYODO

In the study commenced in December, the university will eventually transplant cells derived from iPS cells to four patients who between two to four weeks earlier lost motor and sensory function after sustaining injuries when playing sport or in traffic accidents.

Read more of Keio University Uses iPS Cells in First Treatment of Spinal Cord Injury »


Israeli Biotech Company, Matricelf, Paves a New Way in Healing Injured Spinal Cords

Posted on January 12th, 2022

The company successfully used human implants for replacing the injured spinal cord of a living pig, thereby simulating the anticipated surgical procedure in humans.

Pig

Spinal cord injuries are notoriously difficult to operate on, but an Israeli biotech company has entered a new road on the way to a cure using pigs.

Read more of Israeli Biotech Company, Matricelf, Paves a New Way in Healing Injured Spinal Cords »


Neuroplast Announces Successful Clinical Phase I Trial with Neuro-Cells Stem Cell Treatment for Traumatic Spinal Cord Injury

Posted on November 11th, 2021

Dutch biotech company, Neuroplast, and the Hospital Nacional de Parapléjicos de Toledo in Spain have announced positive clinical Phase I results after analysis of ten patients suffering from traumatic spinal cord injury (TSCI), with data demonstrating that its investigational stem cell treatment, Neuro-Cells, appears to be safe and well tolerated, without product-related adverse events.

The treatment uses the patient’s own stem cells to prevent further loss of function after sustaining TSCI, in an effort to limit loss of mobility and independence of otherwise life-long impairment.

Read more of Neuroplast Announces Successful Clinical Phase I Trial with Neuro-Cells Stem Cell Treatment for Traumatic Spinal Cord Injury »


NeuroRegen Scaffold Transplantation Brings Hope to Spinal Cord Injury Patients

Posted on September 10th, 2021

A joint group of Chinese scientists has recently confirmed the safety and preliminary effective of NeuroRegen Scaffold transplantation for spinal cord injury repair. Results were published in Science China Life Sciences.

NeuroRegen Scaffold transplantation
NeuroRegen Scaffold transplantation (Image by IGDB)

Read more of NeuroRegen Scaffold Transplantation Brings Hope to Spinal Cord Injury Patients »


« Older Entries